Nomura Asset Management CO LTD Alnylam Pharmaceuticals, Inc. Transaction History

Nomura Asset Management CO LTD

$28.9 Billion
Q2 2024

A detailed history of Nomura Asset Management CO LTD transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Nomura Asset Management CO LTD holds 79,297 shares of ALNY stock, worth $21.8 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

79,297

Previous 79,743 0.56%

Holding current value

$21.8 Million

Previous $11.9 Million 61.69%

% of portfolio

0.07%

Previous 0.04%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$143.31 - $247.0 $63,916 - $110,162	-446 Reduced 0.56%	79,297 $19.3 Million
Q1 2024 May 13, 2024	BUY	$146.51 - $198.2 $1.57 Million - $2.13 Million	10,732 Added 15.55%	79,743 $11.9 Million
Q4 2023 Feb 09, 2024	BUY	$151.41 - $196.57 $150,501 - $195,390	994 Added 1.46%	69,011 $13.2 Million
Q3 2023 Nov 03, 2023	BUY	$170.77 - $211.65 $308,069 - $381,816	1,804 Added 2.72%	68,017 $12 Million
Q2 2023 Aug 14, 2023	SELL	$185.01 - $212.05 $200,735 - $230,074	-1,085 Reduced 1.61%	66,213 $12.6 Million
Q1 2023 May 11, 2023	BUY	$182.66 - $235.53 $1.79 Million - $2.31 Million	9,798 Added 17.04%	67,298 $13.5 Million
Q4 2022 Feb 14, 2023	SELL	$185.53 - $241.31 $242,673 - $315,633	-1,308 Reduced 2.22%	57,500 $13.7 Million
Q3 2022 Nov 10, 2022	SELL	$138.54 - $232.0 $301,463 - $504,832	-2,176 Reduced 3.57%	58,808 $11.8 Million
Q2 2022 Aug 12, 2022	SELL	$120.42 - $169.29 $231,928 - $326,052	-1,926 Reduced 3.06%	60,984 $8.89 Million
Q1 2022 May 13, 2022	SELL	$127.18 - $173.91 $78,470 - $107,302	-617 Reduced 0.97%	62,910 $10.3 Million
Q4 2021 Feb 01, 2022	BUY	$159.56 - $209.29 $3.3 Million - $4.33 Million	20,703 Added 48.34%	63,527 $10.8 Million
Q3 2021 Nov 12, 2021	BUY	$169.75 - $207.73 $172,296 - $210,845	1,015 Added 2.43%	42,824 $8.09 Million
Q2 2021 Aug 06, 2021	BUY	$128.63 - $176.89 $153,712 - $211,383	1,195 Added 2.94%	41,809 $7.09 Million
Q1 2021 May 14, 2021	BUY	$126.83 - $175.69 $2.55 Million - $3.53 Million	20,099 Added 97.97%	40,614 $5.73 Million
Q4 2020 Feb 12, 2021	BUY	$122.97 - $147.0 $174,617 - $208,740	1,420 Added 7.44%	20,515 $2.67 Million
Q2 2020 Aug 13, 2020	BUY	$104.21 - $156.44 $52,626 - $79,002	505 Added 2.72%	19,095 $2.83 Million
Q1 2020 May 14, 2020	BUY	$93.12 - $133.99 $93,120 - $133,990	1,000 Added 5.69%	18,590 $2.02 Million
Q4 2019 Feb 13, 2020	SELL	$74.51 - $124.23 $38,000 - $63,357	-510 Reduced 2.82%	17,590 $2.03 Million
Q3 2019 Nov 13, 2019	BUY	$70.9 - $87.82 $323,304 - $400,459	4,560 Added 33.68%	18,100 $1.46 Million
Q4 2018 Feb 12, 2019	BUY	$62.67 - $88.33 $100,272 - $141,328	1,600 Added 13.4%	13,540 $987,000
Q2 2018 Aug 03, 2018	BUY	$88.31 - $107.8 $105,972 - $129,360	1,200 Added 11.17%	11,940 $1.18 Million
Q4 2017 Feb 14, 2018	BUY	$114.49 - $139.98 $1.23 Million - $1.5 Million	10,740 New	10,740 $1.37 Million
Q3 2017 Nov 13, 2017	BUY	$72.53 - $118.27 $0 - $0	0	0 $0

Others Institutions Holding ALNY

# of Institutions

614

Shares Held

108M

Call Options Held

2.33M

Put Options Held

2.17M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $33.8B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.

Account

Nomura Asset Management CO LTD Alnylam Pharmaceuticals, Inc. Transaction History